�this negligence must not be allowed to continue,� budkie�s letter states. �the university of california, berkeley, has clearly failed to follow federal regulations and guidelines.�. february 2016  (27).

despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..